GREAT BAY--The American Cancer Society (ACS) has issued its most specific prostate cancer screening guidelines in more than 15 years, recommending that Black men begin annual prostate cancer testing at age 45, while men at average risk should undergo screening every two years beginning at age 50.
The new recommendations, released on Thursday, November 12, represent a significant change in the organization's approach to detecting one of the most common cancers affecting men. Rather than primarily advising men to discuss screening options with their doctors, the ACS is now recommending regular blood testing at specific ages and intervals.
The updated guidelines are particularly relevant to Caribbean communities, including St. Maarten, where men and healthcare providers can use the recommendations to inform discussions about early detection, family history and individual cancer risk. The guidelines are issued by the American Cancer Society and do not represent a formally announced change to St. Maarten's national healthcare policy.
The recommendations follow growing scientific evidence that prostate-specific antigen (PSA) blood testing can reduce deaths from prostate cancer and help identify potentially dangerous cancers before they spread.
Black men face significantly higher risks
One of the most significant changes involves earlier and more frequent screening for Black men, who face a substantially higher risk of developing and dying from prostate cancer.
According to the American Cancer Society, research in the United States shows that Black men experience a 67 percent higher incidence of prostate cancer and nearly twice the mortality rate compared with White men.
Black men are also more likely to develop the disease at younger ages and to be diagnosed with more aggressive forms of cancer.
Under the updated guidelines, Black men between the ages of 45 and 69 should undergo a PSA blood test every year.
The same annual screening recommendation applies to non-Black men with a strong family history of prostate cancer, including those whose father, brother or son was diagnosed before age 65, or those with multiple first-degree relatives diagnosed at any age.
For men at average risk, the ACS recommends PSA screening every two years between ages 50 and 69.
Non-Black men with one first-degree relative diagnosed at age 65 or older should begin screening at 45, with testing every two years through age 69.
The recommendations aim to identify potentially life-threatening cancers earlier while reducing unnecessary testing and treatment.
The American Cancer Society last updated its prostate cancer screening recommendations in 2010. At that time, questions remained about whether routine PSA testing produced enough benefits to outweigh the risks associated with unnecessary biopsies and treatment.
Since then, new research and improvements in diagnostic procedures have provided stronger evidence that screening can reduce deaths and the number of men diagnosed with advanced prostate cancer.
Dr. William Dahut, chief scientific officer of the American Cancer Society, said the updated recommendations are intended to address disparities in prostate cancer outcomes, particularly among Black men.
The organization also recognizes that advances in medical imaging and monitoring now allow doctors to better determine which cancers require immediate treatment and which can be safely observed.
This is particularly important because not all prostate cancers behave the same way. Some develop aggressively and can spread to other parts of the body, while others grow slowly and may never cause serious health problems.
The updated recommendations also address screening for older men.
For men between ages 70 and 74, the American Cancer Society recommends an individual decision based on overall health, life expectancy, personal preferences and the potential benefits and risks of continued testing.
Routine screening is generally not recommended for men aged 75 and older, although exceptionally healthy men between 75 and 79 may consider continued screening after consulting their doctors, particularly when previous PSA results have been rising.
Screening is not recommended for men aged 80 and older or for those whose life expectancy is less than ten years.
These recommendations reflect evidence that the benefits of screening generally decline with advancing age, while the risks associated with unnecessary investigations and treatment may increase.
What the recommendations mean for St. Maarten
For men in St. Maarten, the updated American Cancer Society guidelines provide an additional basis for discussing prostate cancer screening with healthcare providers.
The recommendations place particular emphasis on Black men, men with a family history of prostate cancer and those who may not have previously considered screening because they experience no symptoms.
They also highlight the importance of understanding family medical history, since having a father, brother or son diagnosed with prostate cancer can influence when screening should begin and how frequently testing should occur.
The ACS guidelines are not identical to recommendations issued by all medical organizations, some of which place greater emphasis on individual decisions about PSA testing.
Men are therefore encouraged to discuss their age, family history, overall health and personal risk factors with their healthcare providers before deciding on a screening schedule.
The central change in the new guidance is that the American Cancer Society now directly recommends regular screening for specific groups of men, based on evidence that earlier detection can reduce the likelihood of advanced disease and death from prostate cancer.
